Colin Terry

@BetafitPPE can someone DM me urgently about your PPE urgently.

@DShaywitz @timmermanreport Good luck in your new venture! R&D productivity needs help to improve based on our@latest analysis @Deloitte

New Year, new role (!), same thesis: aligning tech and pharma to elicit best of both... my latest piece for @timmermanreport about my new job - founder, Astounding HealthTech Advisory Services -- and why i'm so excited by this opportunity: buff.ly/2MNqAvq .

Pharma return on investment for R&D at a decade low, Deloitte report says beckershospitalreview.com/pharmacy/pharm…

Sharp decline in return on R&D for biotech companies over the last 10 years, according to Deloitte.

Pharma return on investment for R&D at a decade low, Deloitte report says beckershospitalreview.com/pharmacy/pharm…

Deloitte: ROI on big pharma’s R&D at all-time low bioworld.com/articles/43196…

@Hermesparcels I’m waiting for a parcel delivery and your website says “delivered and signed for @ 1728” but I’m at home and no parcel. What is going on? Hoping for a response here as your phone line and website dead end with the information above - delivered and signed. It isn’t

@SW_Railway 0930 on a Sunday morning is peak? That’s pretty weird.

@SW_Railway why is it the cheapest off peak return from the machine is £23 but £15 on Trainline? I’ve been ripped off for £16 with two tickets.

☄️ . * . * * 👨‍🚀 🌒👨‍🚀👨‍🚀 * . 🛰️ . * ⭐️ * . . 🚀 * . . . . . * 🌎 * #Apollo50th #WorldEmojiDay

@billforquer Yeet. That’s down with the kids.

My wife has banned me from saying "It is what it is". She says only old ppl say that. Need alternative suggestions please.

@KerriewickhamW @NOWTV Mine. Same.

@NOWTV Nowtv not working on my Apple TV... any idea what’s going on? Is now tv Down?

Discover the strategies that can help #biopharma companies to maximise #RnD return on investment. deloi.tt/2GZNq2I

@paulpetertak Good luck in your new role! Take your passion to a new place.

A quick personal update: I have stepped down from my previous roles as SVP R&D Pipeline, Chief Immunology Officer and Development Lead at GSK to become Venture Partner at Flagship Pioneering. Very excited by the new opportunity!

Great to welcome Prof Sir John Bell to @DeloitteUK to talk about the successes of the Life Science Strategy rolled out over the last year driving investment and patient benefit across the UK @UK_Life_Science @GenomicsEngland @healthinnovmcr @HDR_UK

100k genomes programme nearing completion and moving to a national genomic medicines service. Data from primary care and cancer registries is now being incl in the database... Amazing power and opportunity on show at the GeL Discovery Forum @GenomicsEngland @CSOSue @NHSgms

Excited for @colinterry panel today about the future of #RandD at #FTPharma conference deloi.tt/2qvFB9O

Watch out for the new IRR report in December from #deloitte

Great panel moderated at #ftpharma